You have 9 free searches left this month | for more free features.

Acquired refractory idiopathic aplastic anemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic

Not yet recruiting
  • Refractory Idiopathic Aplastic Anemia
  • Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
  • Allogenic transplantation
  • (no location specified)
Nov 8, 2021

Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))

Recruiting
  • Severe Aplastic Anemia
  • Anti-Thymocyte Globulin (Rabbit)
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Sep 9, 2023

Refractory Aplastic Anemia Trial in Tianjin (Decitabine)

Terminated
  • Refractory Aplastic Anemia
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 25, 2022

Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions Trial (HSCT Arm group)

Not yet recruiting
  • Idiopathic Aplastic Anemia
  • +2 more
  • HSCT Arm group
  • (no location specified)
Jun 10, 2022

Severe Aplastic Anemia (SAA) Trial (Romiplostim, Antithymocyte Globulin, Cyclosporine A)

Not yet recruiting
  • Severe Aplastic Anemia (SAA)
  • (no location specified)
Sep 2, 2022

Eltrombopag Trial in Assiut (Eltrombopag)

Completed
  • Eltrombopag
  • Assiut, Egypt
    Facility of medicine
Jan 13, 2022

Aplastic Anemia Trial in Kanazawa, Tokyo, Seoul (Romiplostim)

Completed
  • Aplastic Anemia
  • Romiplostim
  • Kanazawa, Japan
  • +2 more
Feb 4, 2022

Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)

Recruiting
  • Aplastic Anemia
  • Expanded autologous T regulatory cells
  • London, United Kingdom
    King's College Hospital
Aug 16, 2022

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Severe Aplastic Anemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

Aplastic Anemia Trial in Worldwide (Eltrombopag, hATG, CsA)

Active, not recruiting
  • Aplastic Anemia
  • Phoenix, Arizona
  • +19 more
Jan 19, 2023

Severe Aplastic Anemia Trial in Worldwide (eltrombopag, Cyclosporine)

Completed
  • Severe Aplastic Anemia
  • Ribeirao Preto, SP, Brazil
  • +19 more
Jun 29, 2022

Acquired and Inherited Bone Marrow Failure Syndromes

Recruiting
  • Severe Aplastic Anemia
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 12, 2022

    Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

    Completed
    • Severe Aplastic Anemia
    • Bone Marrow Failure Syndromes
    • Bone marrow transplant
    • +7 more
    • Baltimore, Maryland
    • +1 more
    Feb 10, 2022

    Evaluate Safety and Effectiveness of Hetrombopag in ITP or AA

    Not yet recruiting
    • Primary Immune Thrombocytopenia
    • Aplastic Anemia
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Apr 11, 2022

    Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) Trial run by the NHLBI (Umbilical Cord

    Completed
    • Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
    • Severe Aplastic Anemia (SAA)
    • Umbilical Cord Blood
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 16, 2021

    Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with

    Recruiting
    • Bone Marrow Failure Syndromes
    • MRD-BMT with Fludarabine-based RIC for Acquired AA
    • +2 more
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    May 6, 2022

    Aplastic Anemia Trial in China (Eltrombopag 25 mg)

    Active, not recruiting
    • Aplastic Anemia
    • Eltrombopag 25 mg
    • Nanjing, Jiangsu, China
    • +4 more
    Oct 7, 2021

    Aplastic Anemia, Neutropenia, Pancytopenia Trial run by the NHLBI (Cyclophosphamide, Fludarabine)

    Completed
    • Aplastic Anemia
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 7, 2021

    Bone Marrow Failure Disorders, Aplastic Anemia, Thrombocytopenia Trial in Iowa City (Romiplostim)

    Recruiting
    • Bone Marrow Failure Disorders
    • +4 more
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Jun 4, 2021

    Aplastic Anemia Trial in Worldwide (rabbit antithymocyte globulin)

    Completed
    • Aplastic Anemia
    • rabbit antithymocyte globulin
    • Creteil, France
    • +13 more
    Sep 21, 2021

    Acquired Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Inherited Bone Marrow Failure Syndromes Trial in Philadelphia

    Recruiting
    • Acquired Aplastic Anemia
    • +2 more
    • CliniMACs
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 1, 2022

    Aplastic Anemia Trial run by the NHLBI (Campath-1H, r-ATG, CsA)

    Completed
    • Aplastic Anemia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 2, 2021

    Severe Aplastic Anemia (SAA) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Active, not recruiting
    • Severe Aplastic Anemia (SAA)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    May 12, 2021

    Aplastic Anemia Trial in Seoul (AMG531)

    Completed
    • Aplastic Anemia
    • Seoul, Korea, Republic of
      Korea, Republic of
    Jan 26, 2021